The National Cancer Institute has awarded a five-year grant of more than $2.2 million to UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, to support her research into the immune response in pancreatic cancer, one of the deadliest cancers.
“Understanding the role of immune regulation in pancreatic cancer represents a crucial stepping stone on our way to advancing care for these patients,” said Pylayeva-Gupta, assistant professor in the UNC School of Medicine Department of Genetics. “In addition to furthering our basic understanding of tumor immunobiology, we hope this research will help guide the field toward the design of B-cell targeted therapies against pancreatic cancer.”